ATE399552T1 - 8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4- methoxyphenyl)-1-methylethylü amino üäethyl - 2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür - Google Patents

8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4- methoxyphenyl)-1-methylethylü amino üäethyl - 2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür

Info

Publication number: ATE399552T1
Authority: AT; Austria
Prior art keywords: hydroxy; üäethyl; quinolinonemonohydrochloride; methylethylü; methoxyphenyl
Prior art date: 2004-03-24

Application number

AT05730069T

Other languages

English (en)

Inventor

Fausto Pivetti

Roberto Pighi

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-24

Filing date

2005-03-24

Publication date

2008-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE399552(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-03-24 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2008-07-15 Application granted granted Critical

2008-07-15 Publication of ATE399552T1 publication Critical patent/ATE399552T1/de

Links

-1 AMINO Chemical class 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Quinoline Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT05730069T 2004-03-24 2005-03-24 8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4- methoxyphenyl)-1-methylethylü amino üäethyl - 2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür ATE399552T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04007045		2004-03-24

Publications (1)

Publication Number	Publication Date
ATE399552T1 true ATE399552T1 (de)	2008-07-15

Family

ID=34963779

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05730069T ATE399552T1 (de)	2004-03-24	2005-03-24	8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4- methoxyphenyl)-1-methylethylü amino üäethyl - 2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür

Country Status (30)

Country	Link
US (1)	US20070197586A1 (de)
EP (1)	EP1729773B1 (de)
JP (1)	JP2007530489A (de)
KR (1)	KR20070001946A (de)
CN (2)	CN1929840B (de)
AR (1)	AR048339A1 (de)
AT (1)	ATE399552T1 (de)
AU (1)	AU2005224032A1 (de)
BR (1)	BRPI0508213A (de)
CA (1)	CA2560650A1 (de)
CY (1)	CY1108323T1 (de)
DE (1)	DE602005007871D1 (de)
DK (1)	DK1729773T3 (de)
EA (1)	EA010128B1 (de)
ES (1)	ES2309739T3 (de)
HR (1)	HRP20080495T3 (de)
IL (1)	IL178227A0 (de)
MA (1)	MA28549B1 (de)
MX (1)	MXPA06010515A (de)
NO (1)	NO20064274L (de)
NZ (1)	NZ550010A (de)
PE (1)	PE20060159A1 (de)
PL (1)	PL1729773T3 (de)
PT (1)	PT1729773E (de)
RS (1)	RS50602B (de)
SI (1)	SI1729773T1 (de)
TN (1)	TNSN06249A1 (de)
UA (1)	UA86221C2 (de)
WO (1)	WO2005089760A1 (de)
ZA (1)	ZA200607907B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1953143A1 (de) *	2007-01-30	2008-08-06	CHIESI FARMACEUTICI S.p.A.	Verfahren zur Herstellung von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1H)-Chinolinon-Monohydrochlorid
EP2116537A1 (de) *	2008-05-07	2009-11-11	CHIESI FARMACEUTICI S.p.A.	Polymorph von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-chinolinon Monohydrochlorid
EP2116536A1 (de)	2008-05-07	2009-11-11	CHIESI FARMACEUTICI S.p.A.	Kristallform von 8-Hydroxy-5-[(1r)-1-Hydroxy-2[[(1r)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1h)-Chinolinon-Monohydrochlorid
WO2011015289A1 (en)	2009-08-04	2011-02-10	Chiesi Farmaceutici S.P.A.	8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl] amino]ethyl]-2(1h)-quinolinone hemi-fumarate
EP2360147A1 (de)	2010-02-22	2011-08-24	CHIESI FARMACEUTICI S.p.A.	Verfahren zur Herstellung von kristallinen Partikeln von einem Salz von 8-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-chinolinon (Carmoterol)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8334494D0 (en) *	1983-12-24	1984-02-01	Tanabe Seiyaku Co	Carbostyril derivatives
GB9603237D0 (en) *	1996-02-16	1996-04-17	Sandoz Ltd	Organic compounds
SE9700135D0 (sv) *	1997-01-20	1997-01-20	Astra Ab	New formulation
EP1654001A2 (de) *	2003-08-05	2006-05-10	Boehringer Ingelheim International GmbH	Medikamente zur inhalation mit steroiden und einem betamimetikum
EP1953143A1 (de) *	2007-01-30	2008-08-06	CHIESI FARMACEUTICI S.p.A.	Verfahren zur Herstellung von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1H)-Chinolinon-Monohydrochlorid
EP2116537A1 (de) *	2008-05-07	2009-11-11	CHIESI FARMACEUTICI S.p.A.	Polymorph von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-chinolinon Monohydrochlorid
EP2116536A1 (de) *	2008-05-07	2009-11-11	CHIESI FARMACEUTICI S.p.A.	Kristallform von 8-Hydroxy-5-[(1r)-1-Hydroxy-2[[(1r)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1h)-Chinolinon-Monohydrochlorid

2005
- 2005-03-23 AR ARP050101185A patent/AR048339A1/es not_active Application Discontinuation
- 2005-03-23 PE PE2005000338A patent/PE20060159A1/es not_active Application Discontinuation
- 2005-03-24 CN CN2005800076387A patent/CN1929840B/zh not_active Expired - Fee Related
- 2005-03-24 EA EA200601531A patent/EA010128B1/ru not_active IP Right Cessation
- 2005-03-24 WO PCT/EP2005/003144 patent/WO2005089760A1/en not_active Ceased
- 2005-03-24 RS RSP-2008/0393A patent/RS50602B/sr unknown
- 2005-03-24 HR HR20080495T patent/HRP20080495T3/xx unknown
- 2005-03-24 AT AT05730069T patent/ATE399552T1/de not_active IP Right Cessation
- 2005-03-24 CN CN200910173473A patent/CN101812017A/zh active Pending
- 2005-03-24 DK DK05730069T patent/DK1729773T3/da active
- 2005-03-24 EP EP05730069A patent/EP1729773B1/de not_active Expired - Lifetime
- 2005-03-24 SI SI200530320T patent/SI1729773T1/sl unknown
- 2005-03-24 AU AU2005224032A patent/AU2005224032A1/en not_active Abandoned
- 2005-03-24 MX MXPA06010515A patent/MXPA06010515A/es active IP Right Grant
- 2005-03-24 JP JP2007504359A patent/JP2007530489A/ja not_active Withdrawn
- 2005-03-24 DE DE602005007871T patent/DE602005007871D1/de not_active Expired - Lifetime
- 2005-03-24 KR KR1020067015966A patent/KR20070001946A/ko not_active Ceased
- 2005-03-24 UA UAA200609448A patent/UA86221C2/uk unknown
- 2005-03-24 US US10/593,571 patent/US20070197586A1/en not_active Abandoned
- 2005-03-24 PL PL05730069T patent/PL1729773T3/pl unknown
- 2005-03-24 CA CA002560650A patent/CA2560650A1/en not_active Abandoned
- 2005-03-24 ES ES05730069T patent/ES2309739T3/es not_active Expired - Lifetime
- 2005-03-24 NZ NZ550010A patent/NZ550010A/en unknown
- 2005-03-24 PT PT05730069T patent/PT1729773E/pt unknown
- 2005-03-24 BR BRPI0508213-7A patent/BRPI0508213A/pt not_active IP Right Cessation
2006
- 2006-08-04 TN TNP2006000249A patent/TNSN06249A1/en unknown
- 2006-09-21 NO NO20064274A patent/NO20064274L/no not_active Application Discontinuation
- 2006-09-21 IL IL178227A patent/IL178227A0/en not_active IP Right Cessation
- 2006-09-21 ZA ZA2006/07907A patent/ZA200607907B/en unknown
- 2006-10-23 MA MA29409A patent/MA28549B1/fr unknown
2008
- 2008-09-04 CY CY20081100962T patent/CY1108323T1/el unknown

Also Published As

Publication number	Publication date
ES2309739T3 (es)	2008-12-16
BRPI0508213A (pt)	2007-07-17
EA010128B1 (ru)	2008-06-30
EP1729773B1 (de)	2008-07-02
UA86221C2 (en)	2009-04-10
MA28549B1 (fr)	2007-04-03
WO2005089760A1 (en)	2005-09-29
DE602005007871D1 (de)	2008-08-14
PE20060159A1 (es)	2006-04-04
AU2005224032A1 (en)	2005-09-29
MXPA06010515A (es)	2007-03-30
EP1729773A1 (de)	2006-12-13
CN1929840A (zh)	2007-03-14
CA2560650A1 (en)	2005-09-29
EA200601531A1 (ru)	2007-04-27
CN101812017A (zh)	2010-08-25
JP2007530489A (ja)	2007-11-01
RS50602B (sr)	2010-05-07
HRP20080495T3 (hr)	2008-11-30
NZ550010A (en)	2010-08-27
ZA200607907B (en)	2008-04-30
SI1729773T1 (sl)	2008-10-31
AR048339A1 (es)	2006-04-19
IL178227A0 (en)	2006-12-31
NO20064274L (no)	2006-10-13
PL1729773T3 (pl)	2008-12-31
CY1108323T1 (el)	2014-02-12
DK1729773T3 (da)	2008-10-20
KR20070001946A (ko)	2007-01-04
TNSN06249A1 (en)	2007-12-03
CN1929840B (zh)	2010-12-08
PT1729773E (pt)	2008-09-29
US20070197586A1 (en)	2007-08-23

Legal Events

Date

Code

Title

Description

2008-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1729773

Country of ref document: EP

2011-12-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE602006009036D1 (de)	2009-10-22	Hängendes Bauelement und Herstellungsverfahren
ATE450346T1 (de)	2009-12-15	Schleifartikel und herstellungsverfahren dafür
ATE518856T1 (de)	2011-08-15	Herstellverfahren
PT1757582E (pt)	2016-03-04	Arilalquilaminas e processo para a sua produção
DE60324888D1 (de)	2009-01-08	und Herstellungsverfahren
EP1874143A4 (de)	2010-11-17	Reithose und herstellungsverfahren dafür
EP1832187A4 (de)	2015-04-01	Perücke und perückenherstellungsverfahren
DE602005003722D1 (de)	2008-01-24	Feine Legierungspartikel mit unebenen Oberflächen und zugehöriges Herstellungsverfahren
IL228730A (en)	2016-12-29	Pharmaceutical manufacturing process
ZA200802313B (en)	2008-12-31	Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
PL1868770T3 (pl)	2011-05-31	Sposób tworzenia strukturalnych artykułów ściernych
DE602006001238D1 (de)	2008-07-03	Filter und dessen Herstellungsmethode
DE602006007660D1 (de)	2009-08-20	Duroplastische Zusammensetzung und Herstellungsverfahren
DE602006020117D1 (de)	2011-03-31	Nadellager und herstellungsverfahren dafür
FR2866894B1 (fr)	2008-05-09	Poudre nouvelle traitee en surface
TWI310040B (en)	2009-05-21	Polymethacrylate and production process thereof
DE602005020537D1 (de)	2010-05-27	Koplanarer Filter und zugehöriges Herstellungsverfahren
EP1837413A4 (de)	2010-07-21	Roll-gleit-elemente und herstellungsverfahren dafür
IL183702A0 (en)	2007-09-20	Difluoronucleosides and process for preparation thereof
ITMI20042168A1 (it)	2005-02-12	Processo di preparazione di itopride cloridrato
ATE399552T1 (de)	2008-07-15	8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4- methoxyphenyl)-1-methylethylü amino üäethyl - 2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür
DE602006010414D1 (de)	2009-12-24	Haarknüpfwerkzeug und herstellungsverfahren dafür
GB0515820D0 (en)	2005-09-07	Improved two-part microwell plates and methods of fabricating same
DE112006003255A5 (de)	2008-09-18	Walzenbürste und ihre Herstellungsverfahren
DE602005020712D1 (de)	2010-06-02	Anschlussklemme und Herstellungsverfahren